BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND MALAT1, PRO1073, 378938, Q9UHZ2 AND Prognosis
15 results:

  • 1. Insights into the roles of non-coding RNAs and angiogenesis in glioblastoma: An overview of current research and future perspectives.
    Song Z; Xue Z; Wang Y; Imran M; Assiri M; Fahad S
    Biochim Biophys Acta Gen Subj; 2024 Apr; 1868(4):130567. PubMed ID: 38242182
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Long non-coding RNA panel as a molecular biomarker in glioma.
    Ebrahimi AA; Ashoori H; Vahidian F; Mosleh IS; Kamian S
    J Egypt Natl Canc Inst; 2021 Oct; 33(1):31. PubMed ID: 34693506
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. cancer driver gene and non-coding RNA alterations as biomarkers of brain metastasis in lung cancer: A review of the literature.
    Karimpour M; Ravanbakhsh R; Maydanchi M; Rajabi A; Azizi F; Saber A
    Biomed Pharmacother; 2021 Nov; 143():112190. PubMed ID: 34560543
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Long non-coding RNAs as a predictive markers of group 3 medulloblastomas.
    Mutlu M; Tekin C; Ak Aksoy S; Taskapilioglu MO; Kaya S; Balcin RN; Ocak PE; Kocaeli H; Bekar A; Tolunay S; Tunca B
    Neurol Res; 2022 Mar; 44(3):232-241. PubMed ID: 34533098
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Coexistence of TERT C228T mutation and malat1 dysregulation in primary glioblastoma: new prognostic and therapeutic targets.
    Ak Aksoy S; Mutlu M; Tunca B; Kocaeli H; Taskapilioglu MO; Bekar A; Tekin C; Argadal OG; Civan MN; Kaya İS; Ocak PE; Tolunay S
    Neurol Res; 2021 Nov; 43(11):916-925. PubMed ID: 34210246
    [No Abstract]    [Full Text] [Related]  

  • 6. METTL3 enhances the stability of malat1 with the assistance of HuR via m6A modification and activates NF-κB to promote the malignant progression of IDH-wildtype glioma.
    Chang YZ; Chai RC; Pang B; Chang X; An SY; Zhang KN; Jiang T; Wang YZ
    Cancer Lett; 2021 Jul; 511():36-46. PubMed ID: 33933553
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Long Non-coding RNA malat1 Upregulates ZEB2 Expression to Promote Malignant Progression of Glioma by Attenuating miR-124.
    Cheng H; Zhao H; Xiao X; Huang Q; Zeng W; Tian B; Ma T; Lu D; Jin Y; Li Y
    Mol Neurobiol; 2021 Mar; 58(3):1006-1016. PubMed ID: 33078370
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Long non-coding RNAs as epigenetic mediator and predictor of glioma progression, invasiveness, and prognosis.
    Zhang Y; Xiao Y; Li GC; Gong FY; Zhang XN; Hou K
    Semin Cancer Biol; 2022 Aug; 83():536-542. PubMed ID: 32920124
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Long non-coding RNA malat1 as a key target in pathogenesis of glioblastoma. Janus faces or Achilles' heal?
    Baspinar Y; Elmaci I; Ozpinar A; Altinoz MA
    Gene; 2020 May; 739():144518. PubMed ID: 32119915
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Long noncoding RNA malat1 may be a prognostic biomarker in IDH1/2 wild-type primary glioblastomas.
    Argadal OG; Mutlu M; Ak Aksoy S; Kocaeli H; Tunca B; Civan MN; Egeli U; Cecener G; Bekar A; Taskapilioglu MO; Tekin C; Tezcan G; Tolunay S
    Bosn J Basic Med Sci; 2020 Feb; 20(1):63-69. PubMed ID: 31479414
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. lncRNAs as potential molecular biomarkers for the clinicopathology and prognosis of glioma: A systematic review and meta-analysis.
    Zhou Q; Liu J; Quan J; Liu W; Tan H; Li W
    Gene; 2018 Aug; 668():77-86. PubMed ID: 29777909
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Targeted nanocomplex carrying siRNA against malat1 sensitizes glioblastoma to temozolomide.
    Kim SS; Harford JB; Moghe M; Rait A; Pirollo KF; Chang EH
    Nucleic Acids Res; 2018 Feb; 46(3):1424-1440. PubMed ID: 29202181
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. malat1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression.
    Chen W; Xu XK; Li JL; Kong KK; Li H; Chen C; He J; Wang F; Li P; Ge XS; Li FC
    Oncotarget; 2017 Apr; 8(14):22783-22799. PubMed ID: 28187000
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Long noncoding RNA malat1 associates with the malignant status and poor prognosis in glioma.
    Ma KX; Wang HJ; Li XR; Li T; Su G; Yang P; Wu JW
    Tumour Biol; 2015 May; 36(5):3355-9. PubMed ID: 25613066
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Long noncoding RNA malat1 promotes brain metastasis by inducing epithelial-mesenchymal transition in lung cancer.
    Shen L; Chen L; Wang Y; Jiang X; Xia H; Zhuang Z
    J Neurooncol; 2015 Jan; 121(1):101-8. PubMed ID: 25217850
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.